MedPath

Prevention of Intrathecal Morphine Induced Pruritus: Comparison of Ondansetron and Palonosetron

Not Applicable
Completed
Conditions
Morphine Adverse Reaction
Interventions
Registration Number
NCT01952626
Lead Sponsor
Kyungpook National University Hospital
Brief Summary

Intrathecal administration of morphine is often used for control of postoperative pain. However, pruritus is one of the most common side effects of intrathecal morphine . Specific serotonin receptor antagonists could be an effective prophylactic treatment of neuraxial opioid-induced pruritus. It was reported that palonosetron is more effective than ondansetron for prevention of postoperative nausea and vomiting. Therefore, the investigators evaluated the efficacy of prophylactic administration of ondansetron and palonosetron for the prevention of intrathecal morphine-induced pruritus.

Detailed Description

Intrathecal administration of morphine is often used for relief of postoperative pain. However, pruritus is one of the most common side effects associated with intrathecal morphine. Specific serotonin receptor antagonists such as ondansetron could be an effective prophylactic treatment of neuraxial opioid-induced pruritus. It was reported that palonosetron is more effective than ondansetron for prevention of postoperative nausea and vomiting. Therefore, the investigators evaluated the efficacy of prophylactic administration of ondansetron and palonosetron for the prevention of intrathecal morphine-induced pruritus.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • 19-70 years,
  • American Society of Anesthesiology physical status 1 and 2
  • Scheduled for elective urologic surgery under spinal anesthesia.
Read More
Exclusion Criteria
  • Patients with cardiac and psychological problems.
  • Patients who take sedatives or narcotics.
  • Patient who have allergy to study drugs.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
palonosetronPalonosetronIntravenous administration of palonosetron 0.075mg 15 minutes before spinal anesthesia
ondansetronOndansetronIntravenous administration of ondansetron 4mg 15 minutes before spinal anesthesia
Primary Outcome Measures
NameTimeMethod
Incidence of pruritus24 hours after spinal anesthesia

record of the incidence of pruritus after spinal anesthsia

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kyungpook National Hospital

🇰🇷

Daegu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath